PatrickRyanSosnayMD
Pulmonology • Baltimore, MDCritical Care Medicine
Assistant Professor of Medicine, Johns Hopkins University School of Medicine; Assistant Professor
Dr. Sosnay is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
600 N Wolfe St
Baltimore, MD 21287Phone+1 410-955-3467
Education & Training
Johns Hopkins UniversityFellowship, Pulmonary Disease and Critical Care Medicine, 2003 - 2008- Johns Hopkins UniversityResidency, Internal Medicine, 2000 - 2003
University of Wisconsin School of Medicine & Public HealthClass of 2000
Certifications & Licensure
MD State Medical License 2004 - 2025
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2014
Publications & Presentations
PubMed
- 2 citationsVanzacaftor-tezacaftor-deutivacaftor versus elexacaftor-tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years and older (SKYLINE Trials VX20-121-102 a...Claire Keating, Lael M Yonker, François Vermeulen, Dario Prais, Rachel W Linnemann
The Lancet. Respiratory Medicine. 2024-12-20 - 2 citationsVanzacaftor-tezacaftor-deutivacaftor for children aged 6-11 years with cystic fibrosis (RIDGELINE Trial VX21-121-105): an analysis from a single-arm, phase 3 trial.Jordana E Hoppe, Ajay S Kasi, Jessica E Pittman, Renee Jensen, Lena P Thia
The Lancet. Respiratory Medicine. 2024-12-20 - 21 citationsSafety and efficacy of vanzacaftor-tezacaftor-deutivacaftor in adults with cystic fibrosis: randomised, double-blind, controlled, phase 2 trials.Ahmet Z Uluer, Gordon MacGregor, Pilar Azevedo, Veronica Indihar, Claire Keating
The Lancet. Respiratory Medicine. 2023-06-01
Journal Articles
- Capitalizing on the Heterogeneous Effects of CFTR Nonsense and Frameshift Variants to Inform Therapeutic Strategy for Cystic FibrosisNatalie West, Christian Merlo, Garry R Cutting, Patrick R Sosnay, PLoS One
Press Mentions
International Experts Update Guidelines for Cystic Fibrosis DiagnosisFebruary 6th, 2017
Updated Cystic Fibrosis Diagnosis GuidelinesJanuary 31st, 2017
Scientists Pinpoint 105 Additional Genetic Errors That Cause Cystic FibrosisFebruary 10th, 2016- Join now to see all
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/patrick-sosnay
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
